Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/10/15  and contains information from public web pages.

Board Member

Phone: (650) ***-****  HQ Phone
Local Address: , California, United States
A.P. Pharma Inc
123 Saginaw Drive 123 Saginaw Drive
Redwood City , California 94063
United States

Company Description: A.P. Pharma, Inc. (A.P. Pharma) is a specialty pharmaceutical company focused on developing pharmaceutical products using its Biochronomer polymer-based drug...   more
Background

Employment History

200 Total References
Web References
A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39) | Expert Financial Analysis and Reporting | Smith on Stocks
smithonstocks.com, 10 June 2015 [cached]
A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39) | Read more… | See my recent blog A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39) | Expert Financial Analysis and Reporting | Smith on Stocks SmithOnStocks Logo
...
A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39)
...
The Board of Directors of A.P. Pharma (APPA.OB) has brought in the management team that was responsible for founding the biotechnology company Ardea in 2006 and selling it to Astra Zeneca in April 2012 for $1.3 billion.
...
Robert Rosen, who joined A.P. Pharma in October 2012 as Chief Commercial Officer, will be promoted to the role of President.
...
On the third and final point, A.P. Pharma was unlucky as after submitted its NDA, there was a change in definition in what constituted moderate emetogenic chemotherapy or MEC and what constituted highly emetogenic chemotherapy or HEC.
...
This was a great decision in that A.P. Pharma will probably not be forced to do a new financing at current depressed prices. My analysis suggests that the Company will have about $30 million at the end of 2013. I think that the Company will probably need to raise capital after the approval of APF 530, although perhaps not immediately. I would also point out that new management chose to sell Ardea before it commercialized its lead drug lesinurad and there is a possibility that A.P. Pharma could be sold prior to commercialization of APF 530.
...
A.P. Pharma. APF530 (4)
A.P. Pharma Appoints New ...
phx.corporate-ir.net, 11 Oct 2014 [cached]
A.P. Pharma Appoints New Management Team
...
A.P. Pharma
...
Each executive joined A.P. Pharma's
...
A.P. Pharma
...
A.P. Pharma
...
A.P. Pharma
...
A.P. Pharma's
...
A.P. Pharma
A.P. Pharma
Heron Therapeutics • Board of Directors
www.appharma.com, 28 April 2014 [cached]
Stephen R. Davis joined A.P. Pharma as Executive Vice President and Chief Operating Officer in May 2013 and has served as a member of our board of directors since June 2012.
...
Barry D. Quart, Pharm.D. joined A.P. Pharma in May 2013 as Chief Executive Officer and has served as a member of our board of directors since June 2012.
...
Robert Rosen joined A.P. Pharma as Senior Vice President and Chief Commercial Officer in October 2012 and was appointed to President in May 2013.
...
Prior to joining A.P, Pharma, he served as global head of oncology at Bayer HealthCare, where he was responsible for the development of the global oncology business unit for regions that included the Americas, Europe, Japan, and Asia Pacific from 2005 to 2011. During his tenure at Bayer Healthcare, he led the launch of Nexavar for the treatment of renal cell carcinoma and hepatocellular carcinoma. Nexavar's worldwide sales in 2011 were $1.0 billion. He also led premarket activities for Stivarga for gastrointestinal stromal tumors and colon cancer and alpharadin for prostate cancer.
A.P. Pharma Appoints New ...
phx.corporate-ir.net, 11 Oct 2014 [cached]
A.P. Pharma Appoints New Management Team Heron Therapeutics . A Biotechnology Company • Investor Relations • News Release
...
A.P. Pharma Appoints New Management Team
...
A.P. Pharma
...
Each executive joined A.P. Pharma's
...
A.P. Pharma
...
A.P. Pharma
...
A.P. Pharma
...
A.P. Pharma's
...
A.P. Pharma
A.P. Pharma
Download Documentation | A.P. ...
phx.corporate-ir.net, 11 Oct 2014 [cached]
Download Documentation | A.P. Pharma Announces First Quarter 2013 Financial Results and Highlights Recent Corporate Progress Heron Therapeutics . A Biotechnology Company • Investor Relations • News Release
...
A.P. Pharma Announces First Quarter 2013 Financial Results and Highlights Recent Corporate Progress
...
A.P. Pharma
...
A.P. Pharma's
...
A.P. Pharma
A.P. Pharma
Other People with the name "Pharma":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304